title: Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab.
authors.affiliation: Division of Hematology and Medical Oncology, Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN. Electronic address: nadra@iu.edu.
authors.forename: Nabil
authors.initials: N
authors.lastname: Adra
authors.affiliation: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN.
authors.forename: Liang
authors.initials: L
authors.lastname: Cheng
authors.affiliation: Division of Hematology and Medical Oncology, Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN.
authors.forename: Roberto
authors.initials: R
authors.lastname: Pili
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000077594:Nivolumab
chemical_list: D000911:Antibodies, Monoclonal; D000074322:Antineoplastic Agents, Immunological; D000077594:Nivolumab
keywords: Immunotherapy; Kidney cancer; Therapeutic; Unclassified renal cancer; Undifferentiated